Company release
Nanoform Finland Plc
November 19, 2024
20.45 Finnish time / 19.45 Swedish time
Nanoform Finland Plc – Manager’s Transactions – Albert Hæggström
Helsinki, Finland – Manager’s transaction related to Nanoform Finland Plc’s Member of the Board and CFO Albert Hæggström’s purchase of Nanoform Finland Plc shares:
Nanoform Finland Oyj – Managers’ Transactions
____________________________________________
Person subject to the notification requirement
Name: Albert Haeggström
Position: Member of the Board/Deputy member
Issuer: Nanoform Finland Oyj
LEI: 743700JJO2NU8LBS1592
Notification type: INITIAL NOTIFICATION
Reference number: 85422/5/4
____________________________________________
Transaction date: 2024-11-19
Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)
Instrument type: SHARE
ISIN: FI4000330972
Nature of transaction: ACQUISITION
Transaction details
(1): Volume: 18812 Unit price: 1.168 EUR
Aggregated transactions (1):
Volume: 18812 Volume weighted average price: 1.168 EUR
For further information, please contact:
Henri von Haartman
Director of Investor Relations
+46 7686 650 11
About Nanoform
Nanoform is the medicine performance-enhancing company that leverages best-in-class innovative nanoparticle engineering technologies, expert formulation, and scalable GMP API manufacturing to enable superior medicines for patients. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services, from pre-formulation to commercial scale. Nanoform will help improve bioavailability and drug delivery profiles, drive differentiation, patient adherence and extend the lifecycle potential of products. Nanoform’s shares are listed on the Premier-segment of Nasdaq First North Growth Market in Helsinki (ticker: NANOFH) and Stockholm (ticker: NANOFS). Certified Adviser: Carnegie Investment Bank AB (publ), +46 8-588 68 570. For more information, please visit www.nanoform.com.